| Source: |
| Type: |
| AKR1B1 - Aldo-Keto Reductase Family 1 Member B1 / Aldose Reductase Abbreviation: AKR1B1, AR, ALR2, Aldose Reductase Type: NADPH-dependent aldo-keto reductase / polyol pathway enzyme Function: AKR1B1 catalyzes the NADPH-dependent reduction of glucose to sorbitol in the polyol pathway and also reduces reactive aldehydes and other carbonyl compounds. It contributes to redox balance, glucose metabolism, inflammatory signaling, prostaglandin metabolism, and cellular responses to oxidative stress. Cancer: ↑ Frequently overexpressed or functionally activated in cancer. Increased AKR1B1 can promote inflammatory signaling, proliferation, survival, epithelial-mesenchymal transition, migration, invasion, and treatment resistance through pathways involving NF-κB, AKT/mTOR, ROS-responsive signaling, and prostaglandin metabolism. AKR1B1 inhibition has shown predominantly anticancer effects in preclinical studies. |
| 8054- | KAE, | Kaempferol Improves Alzheimer's Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4/AKR1C3 Signaling Pathway |
| - | vitro+vivo, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1752 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid